AI-assisted, human-published
02/19/2025 /Funding Events
EnPlusOne Biosciences Secures $10M to Enhance RNA Synthesis Platform
EnPlusOne Biosciences raises approximately $10 million with Northpond Ventures and Breakout Ventures leading the funding round. The company focuses on scaling its siRNA platform and accelerating high-purity guide RNA synthesis for gene editing.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com